$ZEOX Cashflow Statement | Understand Stock

$ZEOX

$1.20 +$0.00 (0.0%) Close

$ZEOX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2024 12 months to Oct 31, 2025	FY2023 12 months to Oct 31, 2024	FY2022 12 months to Mar 6, 2024	FY2021 12 months to Oct 31, 2022	FY2020 12 months to Oct 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense
Interest expense on conversion of Funding Facility
Depreciation and amortization expense
Amortization of OID and commitment fee discount – Promissory Note
Change in Commitment Fee Shortfall Obligation
Amortization of OID and commitment fee discount – Promissory notes
Amortization of debt discount – Promissory notes
Bad debt expense
Gain from write-off of liabilities attributable to discontinued operations
Gain from write-offs and settlements of accounts payable and notes payable
Change in obligation to repurchase shares
Inducement expense to convert Notes
Write-off of advances payable to former officer
Reserve of non-marketable securities – related party
Reserve for bad debt
Write-off of inventory
Stock issued in settlement of litigation
Stock compensation costs
Accounts receivable, net of allowance for bad debts
Receivables from related party
Other receivable
Prepaid expenses
Inventories
Accounts payable and accrued expenses
Accrued liabilities to management
Security deposits
Deferred revenue

Net cash used in operating activities
CASH FLOWS FROM INVESTING
Purchase of fixed assets
Investment in non-marketable equity securities related party
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of notes payable
Payments on finance lease
Capital contributed by former executive
Proceeds from exercise of warrants
Shares repurchased in connection with litigation
Payments on finance leases
Repayments of Promissory notes
Proceeds from sale of common stock

Net cash provided by financing activities
Decrease in cash
Cash at beginning of period
Cash at end of period
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for taxes
Cash paid for interest

NON-CASH INVESTING AND FINANCING TRANSACTIONS:
Conversion of debt and accrued interest into common stock
Executive forgiveness of employment obligations in connection with Restructuring
Warrants issued to executives as payment for outstanding compensation
Stock issued in exchange for accounts payable
OID discount on proceeds received from Promissory Note
Stock purchased from payments due on accounts payable
Common stock issued as commitment fee for Promissory Note
Commitment Fee Shortfall Obligation
Commitment to repurchase shares in connection with settlement of litigation
Promissory note issued for past due Professional Fees
Purchase of fixed assets included in accounts payable
Exchange of accounts payable for common stock
Stock issued for future services
Operating lease – right of use assets
Reduction in accounts payable for equipment returned to vendor
Exchange of shares for payables
Finance lease obligations
Stock issued Purchase of BioLumina assets
Conversion of notes payable and accrued interest for equity
Royalty payable in connection with purchase of BioLumina assets
Obligation to repurchase shares in connection with purchase of BioLumina assets

Comments